Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Broadfoot Jill Marie
aTyr Pharma, Inc. (ATYR)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
ATYR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATYR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATYR alerts
High impacting aTyr Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
ATYR
News
- aTyr Pharma (ATYR) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ATYR&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hoMarketBeat
- aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma (ATYR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate UpdateGlobeNewswire
ATYR
Earnings
- 11/6/25 - Miss
ATYR
Sec Filings
- 3/12/26 - Form PRE
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- ATYR's page on the SEC website